The VA Enterprise Procurement Office intends to issue an unrestricted RFP for Imatinib Mesylate Tablets for VA (including CMOPs and Option 2 State Veterans Homes), DoD (including Tricare Mail Order Pharmacies), BOP, IHS, and FHCC, awarding one contract to an offeror able to provide uninterrupted supply. The contract will run one year plus four pre-priced one-year option periods, with products distributed through the VA and DoD Pharmaceutical Prime Vendor Programs. Estimated annual requirements are 6,397 bottles of 100 mg/90-count tablets and 23,212 bottles of 400 mg/30-count tablets. Offerors must provide a unique NDC and exact label name, with specific bottle, safety-cap, and labeling requirements, and the acquisition is subject to WTO GPA and Free Trade Agreements. The solicitation will be issued electronically on or about October 16, 2026, in commercial-item format under FAR Part 12, and interested offerors should monitor SAM.gov for amendments.